February 2026
The global terbinafine hydrochloride drug market size was evaluated at USD 1.46 billion in 2025 and is predicted to hit around USD 3.43 billion by 2035, growing at a CAGR of 8.92%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
June 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global sarcoidosis drug market size was estimated at USD 8.82 billion in 2025 and is expected to hit around USD 15.93 billion by 2035, growing at a CAGR of 6.09%.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
June 2026
The global drug-eluting balloon catheters market size was valued at USD 1.53 billion in 2025 and is expected to hit around USD 4.28 billion by 2035, growing at a CAGR of 10.83%.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
June 2026
The global thin film drug manufacturing market size is estimated to hit around USD 15.50 billion by 2035, increasing from USD 7.93 billion in 2025, with a CAGR of 6.93%.
June 2026
The global dermatology drugs market size was calculated at USD 23.86 billion in 2025 and is projected to hit around USD 69 billion by 2035 with a CAGR of 11.2% .
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The global CNS drug discovery market size was evaluated at USD 9.80 billion in 2025 and is predicted to hit around USD 27.55 billion by 2035, growing at a CAGR of 10.90%.
June 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
June 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.29 billion in 2025 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
June 2026
The global drug repurposing market size is estimated to hit around USD 62.24 billion by 2035, increasing from USD 36.87 billion in 2025, with a CAGR of 5.38%.
June 2026
The US cardiovascular drugs market size was evaluated at USD 28.42 billion in 2025 and is predicted to hit around USD 37.03 billion by 2035, growing at a CAGR of 2.68%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global drug screening market size is exhibited at USD 10.55 billion in 2025 and is anticipated to attain around USD 43.72 billion by 2035 with a CAGR of 15.28%.
June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
June 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com